A Nomogram Predicting Lymph Node Metastasis in Patients with Prostate Cancer Undergoing Ultrasound-Guided Transrectal Prostate Biopsy

[1]  H. Zeng,et al.  Pelvic lymph node dissection and its extent on survival benefit in prostate cancer patients with a risk of lymph node invasion >5%: a propensity score matching analysis from SEER database , 2019, Scientific Reports.

[2]  K. Haustermans,et al.  Development and External Validation of a mpMRI- and ISUP-Based Add-on Prediction Tool to Identity Prostate Cancer Candidates for Pelvic Lymph Node Dissection. , 2019, The Journal of urology.

[3]  F. Ameye,et al.  Development and external validation of a nomogram to predict lymph node invasion after robot assisted radical prostatectomy. , 2019, Urologic oncology.

[4]  S. Verma,et al.  Prostate biopsy: when and how to perform. , 2019, Clinical radiology.

[5]  Ying Hou,et al.  A machine learning‐assisted decision‐support model to better identify patients with prostate cancer requiring an extended pelvic lymph node dissection , 2019, BJU International.

[6]  Ying Hou,et al.  A machine learning‐assisted decision‐support model to better identify patients with prostate cancer requiring an extended pelvic lymph node dissection , 2019, BJU international.

[7]  Huihui Wang,et al.  Preoperative PI-RADS Version 2 scores helps improve accuracy of clinical nomograms for predicting pelvic lymph node metastasis at radical prostatectomy , 2019, Prostate Cancer and Prostatic Diseases.

[8]  C. Amling,et al.  The estimated prevalence of missed positive lymph nodes based on extent of lymphadenectomy at radical prostatectomy. , 2019, Urologic oncology.

[9]  Yuehua Wu,et al.  Development and internal validation of a novel model and markers to identify the candidates for lymph node metastasis in patients with prostate cancer , 2019, Medicine.

[10]  Christopher P. Filson,et al.  Rise in Node-Positive Prostate Cancer Incidence in Context of Evolving Use and Extent of Pelvic Lymphadenectomy. , 2019, Clinical genitourinary cancer.

[11]  Liqun Zhou,et al.  Short-term benefit of neoadjuvant hormone therapy in patients with localized high-risk or limited progressive prostate cancer , 2019, Cancer management and research.

[12]  M. Shiota,et al.  Reconsideration on Clinical Benefit of Pelvic Lymph Node Dissection during Radical Prostatectomy for Clinically Localized Prostate Cancer , 2019, Urologia Internationalis.

[13]  F. Montorsi,et al.  A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies. , 2019, European urology.

[14]  Steven L. Chang,et al.  Evaluation of Intense Androgen Deprivation Before Prostatectomy: A Randomized Phase II Trial of Enzalutamide and Leuprolide With or Without Abiraterone. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  O. Rouvière,et al.  The current role of prostate multiparametric magnetic resonance imaging , 2018, Asian journal of urology.

[16]  Christopher U. Jones,et al.  Gleason pattern 5 is associated with an increased risk for metastasis following androgen deprivation therapy and radiation: An analysis of RTOG 9202 and 9902. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  J. Epstein,et al.  Prostate cancer grading: a decade after the 2005 modified system , 2018, Modern Pathology.

[18]  Todd McNutt,et al.  Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study. , 2017, International journal of radiation oncology, biology, physics.

[19]  F. Montorsi,et al.  Development and Internal Validation of a Novel Model to Identify the Candidates for Extended Pelvic Lymph Node Dissection in Prostate Cancer. , 2017, European urology.

[20]  A. Ginori,et al.  Lymphatic Vascularization in Prostate Adenocarcinoma: Correlation with Tumor Grade, Androgen Withdrawal and Prognosis. , 2015, Anticancer research.

[21]  U. Capitanio,et al.  Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores. , 2012, European urology.

[22]  A. Kirschenbaum,et al.  Overview of prostate anatomy, histology, and pathology. , 2011, Endocrinology and metabolism clinics of North America.

[23]  Guilherme Godoy,et al.  Extent of pelvic lymph node dissection and the impact of standard template dissection on nomogram prediction of lymph node involvement. , 2011, European urology.

[24]  F. Montorsi,et al.  Validation of a nomogram predicting the probability of lymph node invasion based on the extent of pelvic lymphadenectomy in patients with clinically localized prostate cancer , 2006, BJU international.

[25]  F. Montorsi,et al.  Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy. , 2006, European urology.

[26]  R. Sutherland,et al.  Lymphatic vessel density and lymph node metastasis in prostate cancer , 2005, The Prostate.